EULAR 2018

Research news

20-06-2018 | Lupus nephritis | EULAR 2018 | News

Abatacept fails to boost renal response rate in lupus nephritis

The addition of abatacept to standard therapy does not increase the rate of complete renal response among patients with lupus nephritis, phase III study findings show.

20-06-2018 | Juvenile idiopathic arthritis | EULAR 2018 | News

No increase in JIA-associated uveitis risk with etanercept treatment

Patients with juvenile idiopathic arthritis who are treated with etanercept do not have a higher risk for developing uveitis than those given methotrexate, results of a UK cohort study suggest.

20-06-2018 | Systemic lupus erythematosus | EULAR 2018 | News

Encouraging long-term safety findings for belimumab in SLE

Belimumab, a B-lymphocyte stimulator specific inhibitor used for the treatment of systemic lupus erythematosus, has a stable safety profile over 8 years of follow-up, with no new safety signals observed, report researchers.

19-06-2018 | Rheumatoid arthritis | EULAR 2018 | News

Depression and anxiety closely linked to RA disease activity

18-06-2018 | Rheumatoid arthritis | EULAR 2018 | News

Synovial gene signatures associated with later RA onset

18-06-2018 | Psoriatic arthritis | EULAR 2018 | News

Low rates of radiographic progression with secukinumab treatment in PsA patients

17-06-2018 | Rheumatoid arthritis | EULAR 2018 | News

Blood test predicts at-risk individuals likely to develop RA in the short term

16-06-2018 | Psoriatic arthritis | EULAR 2018 | News

Benefits of risankizumab maintained for 24 weeks in patients with PsA

15-06-2018 | Rheumatoid arthritis | EULAR 2018 | News

MRI monitoring of treated RA patients does not improve clinical and radiographic outcomes

15-06-2018 | Systemic lupus erythematosus | EULAR 2018 | News

Baricitinib shows promise in SLE

15-06-2018 | Ankylosing spondylitis | EULAR 2018 | News

Self-harm risk increased following ankylosing spondylitis diagnosis